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Abstract
Background: Remote measurement technologies (RMTs) can be used to collect data on a variety of bio-behavioural variables,
which may benefit the care of people with central nervous system disorders. While various studies have explored their potential,
prior work has highlighted a knowledge gap concerning healthcare professional’s perception of the value of RMTs in clinical
practice.
Objective: To understand the perspectives of healthcare professionals on the implementation of RMT in healthcare practice for
the care of people with depression, epilepsy or multiple sclerosis.
Methods: Semi-structured interviews were conducted with 26 multidisciplinary primary and secondary care healthcare
professionals managing people with epilepsy, depression or multiple sclerosis. Interviews were transcribed verbatim and
analysed using thematic analysis.
Results: also indicate points in care pathways at which healthcare staff would most benefit from RMT data, and demonstrate that
healthcare professionals are pragmatic about data security risks arising from using patients’ RMT data.
Conclusions: RMTs could add value to the system of care for individual patients with central nervous system disorders through
providing clinicians with graphic summaries of data in the patient record. Barriers of both technical and human nature should be
considered when implementing these technologies, as should the limits to the benefits they can offer.
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Abstract
Background: Remote measurement technologies (RMTs) can be used to collect data on a variety of
bio-behavioural  variables,  which  may  benefit  the  care  of  people  with  central  nervous  system
disorders.  While  various  studies  have  explored  their  potential,  prior  work  has  highlighted  a
knowledge gap concerning healthcare professional’s  perception of the value of RMTs in clinical
practice.
Objective:  To understand the  perspectives  of  healthcare professionals  on the implementation of
RMT in healthcare practice for the care of people with depression, epilepsy or multiple sclerosis. 
Methods:  Semi-structured  interviews  were  conducted  with  26  multidisciplinary  primary  and
secondary  care  healthcare  professionals  managing  people  with  epilepsy,  depression  or  multiple
sclerosis. Interviews were transcribed verbatim and analysed using thematic analysis.
Results: Eight main themes emerged from the analysis. These were: potential clinical value of RMT
data, when to use RMT in care pathways, healthcare staff roles who may use RMT data, presentation
and accessibility of data, obstacles to successful implementation of RMT, limits to the role of RMT,
empowering patients, and considerations around alert-based systems. 
Conclusions:  RMTs could  add  value  to  the  system of  care  for  individual  patients  with  central
nervous system disorders through providing clinicians with graphic summaries of data in the patient
record. Barriers of both technical and human nature should be considered when implementing these
technologies, as should the limits to the benefits they can offer.
Keywords
Epilepsy;  multiple  sclerosis;  depression;  wearables;  remote  measurement  technology;
clinicians; healthcare professionals; mobile phones; mhealth; digital health; ehealth
Introduction
In  a  healthcare  context,  remote  measurement  technologies  (RMTs)  can  be  used  by  healthcare
professionals (HCPs) and clinical teams to collect data on a patient’s health or behaviour, to inform
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clinical decision-making. The benefits of RMTs have been explored for treatment/management of
patients with cardiac conditions [1-3], early stage dementia [4], neurological disease [5] and attention
deficit hyperactivity disorder (ADHD)  [6] as well as in behaviour change  [7] and monitoring for
indicators of sepsis [8] among others. 
The European Union H2020 RADAR-CNS project [9] explores the use of RMT in the care of people
with epilepsy,  depression or multiple  sclerosis.  These conditions  were chosen for this  project  as
exemplars of central nervous system disorders which are under-researched in relation to RMT. As
part  of  this  project,  RADAR-Base,  a  cloud-based  platform,  is  being  developed  to  explore  the
potential  to  receive  data  from patients’ RMT and to  provide  this  data  to  HCPs  with  a  view to
informing clinical decision-making  [10]. The present study is part of this project, aiming to scope
and understand the clinical  utility  of  RMT in the care of patients  with epilepsy,  depression and
multiple-sclerosis. 
Previous literature has demonstrated the benefits of implementing RMTs in healthcare practice. A
2013 literature  review of  uses  of  RMT in cardiology identified a  number  of  studies  evidencing
reduced hospital  visits  in  terms of  both  emergency and routine  appointments,  as  well  as  higher
survival rates, in patients who were monitored using RMT [11]. Benefits were also found in patient
relations with the care team, quality of life, and compliance with treatments. No quality appraisal
was conducted in this narrative review, however. 
Some work has challenged these findings, suggesting little or no evidence for an effect of RMT on
key outcomes [12, 13]. Other work has highlighted a number of barriers to implementing RMTs in
healthcare practice. Erdmier et al. [14] describe a lack of regulatory control over wearables, and also
a  number  of  barriers  to  progress  in  implementation,  including  technical  capability,  erratic  user
(patient) behaviour and a lack of transparency from manufacturers. A patient and HCP-led priority
setting exercise in the field of digital mental health highlighted the need to explore the impact of
removing face-to-face human interaction in care pathways for mental health conditions, and also
raised issues of safety, effectiveness, evaluation and inequalities [15]. These issues apply equally to
the implementation of RMTs. 
Authors of prior work in the area of RMTs highlight a need for research to investigate the value to
HCPs of implementing RMTs [13]. Davis et al [16] conducted a systematic review of healthcare staff
views of utilising RMT in clinical practice and included 15 relevant studies. They concluded that
“there is a critical need to engage end-users in the development and implementation of RMT” and
highlighted that the evidence base in this area is small. This paper seeks to address these points by
exploring  HCP perspectives  on  the  implementation  of  RMTs  in  three  central  nervous  system
disorders. 
Methods
Aim
The  study  aimed  to  understand  the  perspectives  of  HCPs  on  the  implementation  of  RMT  in
healthcare practice for the care of people with depression, epilepsy or multiple sclerosis (MS). 
Recruitment
We purposively recruited a sample of 26 HCPs, with the intention of covering multiple clinical roles
(with representation from medical,  nursing and allied health  professionals).  Participants were all
working in  the  National  Health  Service  (NHS)  in  England in  the  care  of  people  with  epilepsy,
depression, or multiple sclerosis, or a combination of these conditions. Participants were contacted
through the professional networks of research team members.
Procedure
A semi-structured interview approach was deployed, with interviews lasting from 16 to 56 minutes
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(mean 30 minutes). An interview schedule was used to guide questioning, with ad hoc follow-up
questions  used  to  further  explore  salient  points.  Participants  gave  informed  consent  and  were
incentivised with a £15 charity donation.
Twenty three interviews were conducted one to one, while one interview was conducted with three
participants  together.  Thirteen  of  the  interviews  were  conducted  by  phone,  while  eleven  were
conducted in person. All interviews were recorded start to finish using a voice recorder. The study
was approved by the University of Nottingham School of Medicine research ethics committee (ref
277-1802). 
Analysis
Interviews were transcribed verbatim and analysed using thematic analysis  [17]. Data were coded
and themed (by JA) using Nvivo 12 (QSR International). Initial codes and themes were discussed
within the research team and were iteratively renamed and reformed throughout the analysis process.
No new themes emerged when the last interview was coded and so it is considered that the sample
reached data saturation.
Results
Participants
Participants  were  HCPs  (medical  doctors,  nurses,  clinical  psychologists,  physiotherapist  and
dietitian) from 13 NHS trusts (healthcare organisations) within England. Eight out of 26 participants
(31%) were female. Six specialised in the care of people with depression, 12 in epilepsy, six in MS,
and two were general practitioners working across all three conditions. Participants included both
primary and secondary care clinicians. Thirteen of the 26 interviewees had used RMT with their
patients, and 14 of 26 said their patients had brought data to appointments. Healthcare roles of the
participants are presented in Table 1, along with their specialism and gender. 
Clinical specialism Depression
(n=6)
Epilepsy
(n=12)
MS
(n=6)
Generalist
(n=2)
TOTAL
(n=26)
Gender: n female (%) 1 (16.7) 4 (33.3) 2 (33.3) 1 (50) 8 (30.8)
Job role:
        Psychiatrist
        Psychologist
        Neurologist
        Dietician
        Specialist nurse
        Physiotherapist
        General practitioner
4
1
-
-
1
-
-
-
-
6
1
4
-
1
-
2
3
-
-
1
-
-
-
-
-
-
-
2
4
3
9
1
5
1
3
Table 1. Job roles, genders and specialisms of interview participants.
Thematic analysis
Our analysis generated eight main themes, each of which also featured a number of subthemes. 
Theme 1: Potential clinical value of remote measurement data
The interviews explored the types of physiological, psychosocial and lifestyle variables that could be
targets for measurement using RMTs. HCPs described uses for certain variables they considered to
be potentially useful in the care of people with one of the three conditions. Variables considered by
participants to hold potential are summarised in table 2. 
Condition Variable
Epilepsy Activity,  anxiety,  cognition,  diet/food
intake1,  heart  rate2,  mood,  quality  of  life,
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seizures (or proxies thereof), sleep.
Depression Activity,  anxiety,  diet/food  intake,  mood,
relapse signatures, sleep, weight.
Multiple Sclerosis Activity/mobility,  anxiety,  cognition,
fatigue,  mood,  pain,  quality  of  life,  visual
acuity.
Notes:
1) Opposing views on the value of measuring diet were offered by different participants.
2) It was noted that heart rate would be worth measuring in epilepsy only if proven to be a proxy measure of seizures.
Table 2. Target variables considered potentially useful to measure using RMT.
Epilepsy: Participants stated that it would be useful to collect data from RMTs that could indicate the
occurrence  of  a  seizure  or  number  of  seizures,  especially  in  those  who  have  many.  However
participants  thought  that  current  approaches  to  seizure  detection  (e.g.  Empatica,  Embrace)  were
limited by lack of sensitivity to detect the full range of seizure types:
“The  limitations  of  this  particular  device  is  that  it  is  designed  for  detecting  repetitive
movements which is of use for tonic clonic seizures, however,  there are different types of
seizures which definitely don’t all involve movement but are still epileptic so they wouldn’t be
able to detect that [..] It would be ideal to have something where all types of seizures would
be recorded.” (P02)
Several types of RMT data were mentioned by participants as possible proxy measures of seizures.
These  were:  skin  conductance,  heart  rate,  accelerometry,  pressure  sensor  readings,  and
electroencephalography (EEG).  There were differing views on the usefulness of measuring heart
rate and bed pressure as proxy measures for seizures given the possibility of false positive signals
(i.e. lack of specificity). 
Video  and  audio  might  be  utilised  remotely  to  assist  with  diagnosis  and  seizure  identification,
particularly through measurement of the sound and duration of a seizure.
“I will sometimes tell people who struggle to video their loved one in a seizure for whatever
reason, just to start the video going, put the phone down, and then it will both record the
sound, and the duration of the seizure, which are probably the two most useful things we
need, outside of seeing one.” (P09)
Depression: Activity data, including movement and GPS (global positioning system), was thought
useful in detecting whether a patient was “leaving the house” (P21) or “getting out and about” (P06),
which in turn could be considered a potential “proxy marker of depression severity” (P16). This was
also thought to have potential to indicate a patient’s global level of functioning. RMT data was also
thought to offer a level of objectivity in the measurement of depression which was otherwise lacking.
Prospective mood monitoring using an electronic diary, and measurement of sleep using wearables,
were also mentioned as potentially helpful in managing depression, where current systems such as
Fitbits and mood diary apps could not collate this information together automatically.
MS: Participants saw potential in the use of RMT to measure fatigue, via a self-report app, and also
cognition given its association to relapse. However, some considered it difficult to pick one particular
aspect of MS to measure using RMT, because the symptoms experienced by patients vary:
“I don’t think you can have a particular tool that you would need to use for everyone. I think
it is largely going to be dependent on the symptom profile.” (P20)
Multiple participants mentioned visual acuity as an important indicator of relapse which could be
measured using RMT, although they were unsure if technology would be able to measure it when
even well trained humans struggled:
“It would have to be really well designed to pick up those intricacies [..] sometimes it is really
difficult even for the neurologist to say this person is having a relapse or they are not” (P19)
Theme 2: When to use RMT in the care pathway
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Participants described different points in care pathways when data from RMTs could usefully inform
the care of their patients. Figures 1 to 3 demonstrate where participants indicated it could be useful to
receive data from RMTs. Clinicians indicated that they would like data collected via RMT to be
readily accessible in their electronic patient record when patients attended for appointments.
NB. It  is  acknowledged that not every patient’s  journey along a care pathway follows the same
trajectory. These figures are for illustrative purposes only. 
Figure  1.  Participant  comments  about  timing  of  the  use  of  RMT in  the  epilepsy  care  pathway,
including  monitoring on a yearly basis once stable to allow assessment of follow-up and to create
data for future research.
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Figure 2. Participant comments about timing of the use of RMT in the depression care pathway,
including monitoring during a change in treatment.
Figure  3.  Participant  comments  about  timing  of  the  use  of  RMT in  the  multiple  sclerosis  care
pathway, indicating the benefits of monitoring for a short period of time prior to an appointment.
Theme 3: Healthcare staff roles who may use RMT data
Participants  discussed  the  healthcare  staff  roles  that  should  be  involved in  using any data  from
RMTs. Across all three conditions, participants suggested that primary care was a good place for data
to be managed, given the systems available.
“Primary care is certainly quite well set up with systems in place to action on things based
through the electronic patient record.” (P06)
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In secondary care, specialist nurses were considered to have the closest relationships with patients
among members of the care team, and thus were suggested to be the team member most likely to
review data from RMTs. For example, in epilepsy:
“If it’s sort of data that is being in some way downloaded in between clinics, then there would
certainly be a role for something like an epilepsy nurse to look at that data.” (P09)
Participants  considered  it  important  that  all  clinical,  but  not  administrative,  members  of  a  team
involved in the treatment of a patient should have access to RMT data when it is collected.
“The discussions we’ve had are about, is it  appropriate for admin staff to review that or
actually does it have to be a clinician from a risk perspective [..] Your economic arguments
come in about experienced clinicians are too expensive but I think making the wrong triage
decision is also too expensive.” (P21)
Theme 4: Presentation and accessibility of RMT data
Participants had a variety of views on the best way for data to be presented to them. Particular
emphasis was placed on the importance of interoperability and the ability for any data from RMTs to
be accessible within an existing electronic patient record (EPR) system rather than requiring the
opening of another window or program.
“If  [..] you want to have the information available to you at times other than when your
patient is there, then it would be good if it could feed directly into your electronic patient
record.” (P07)
Across all three conditions, HCPs were keen to have data aggregated in a visual/ graphical format.
Some also recalled instances where they had used devices or software which presented information
in  graphs  automatically,  and commented  that  this  was  useful  for  the  patient  as  well  as  for  the
clinician.
 “For most of them [mood-reporting apps] you can do a graph function so they can show you
the whole three months, in a fairly small chart, which helps us to think about if there have
been any stresses or life events that have changed their mood or whether there’s a pattern to
the time of day, and so on.” (P07)
Speed of access to information was also considered to be a priority. Participants spoke of particular
situations in which the use of digital records could usefully increase efficiency through time-saving.
“I certainly think if you can access the information quickly then it could be a focus point for
the whole consultation and it could speed things up.” (P16)
Uploading data to the EPR was considered preferable to reviewing data that patients brought to the
clinic on their mobile phones.
“It could be sent in and loaded up in the patients notes or some other big screen device
otherwise you are kind of stuck with little handheld mobiles and it’s not really that helpful.”
(P13)
Theme 5: Obstacles to successful implementation of RMTs
Participants mentioned several aspects of the use of RMTs which they considered to be obstacles to
their successful use and adoption in practice. These fitted into two broad categories of ‘technical
issues’ and ‘human issues’. 
The most frequently mentioned technical issue was data accuracy (“I’m not sure they’re accurate”,
P03). However, participants indicated they would be happy to use devices even where these provided
data which were not 100% accurate, so long as the clinician was aware of the margins of error that
the data may contain.
“So being as clear as possible what the potential pitfalls might be about all the data that we
get back  [..] I think as long as you know, kind of where it might go wrong, or how to be
careful which bits to not over-interpret, then I think it’s fine” (P09)
There  was  also  concern  about  the  interoperability  of  any  new  systems  with  existing  ones,  as
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clinicians are already required to use several different software packages to manage patients.
“The main trouble currently is a lack of integration” (P01)
Data  security  was  also  discussed  as  an  important  issue  to  consider,  although  participants  had
differing views on the level of risk that providing data remotely may entail. Some had concerns.
 “Who has access to this data? Including if they have it on their phone, what if their phone
goes missing, where does this data go? There’s a big big, data protection bit, there’s a big
big, patient safety bit.” (P03)
Some advocated taking a pragmatic  approach to reduce risk while continuing to use technology
where it provided a benefit.
“I think as long as appropriate safeguards are taken then that’s fine, and I think sometimes
this can be a barrier, an unnecessary barrier to introducing things that can be helpful.” (P06)
Human issues considered obstacles to the use of RMTs largely focused on two areas: patient anxiety
and patient motivation. Participants discussed ways in which the use of RMTs may cause patients
anxiety through over-focussing on their symptoms, and how this in turn could be problematic for a
health service.
“We have had quite a few patients coming in that have used these monitoring devices and say
my heart rate is really fast. For them it’s another layer of education so it actually creates us
more work.” (P03)
However, others were less concerned, believing that RMTs would not induce anxiety in people who
were not prone to it in the first place or that any anxiety would be manageable.
“We’ve always found ways to react to that anxiety, this is just what it looks like in the current
generation.” (P21)
Participants  suggested  that  patients  with  depression  would  have  less  motivation  to  engage with
RMTs as a result of their condition. 
“A lot  of  our  patients  may,  especially  if  they’re  more  severely  depressed,  not  be  very
motivated to interact with the app” (P16)
However,  the  use of  RMTs to  generate  more  objective  evidence  of  a  patient’s  health  state  was
considered by some to be useful in motivating engagement with their care.
“So if you do your usual interview and you’ve got objective evidence to say, I think your
depression is coming back or you haven’t been exercising enough or you have way more
seizures than you think, then of course, that might help motivating them to do certain things.”
(P22)
Theme 6: Limits to the role of RMT
Several  of our  participants  mentioned elements  of care in their  specialism which,  in  their  view,
should  not  be  replaced  by  an  RMT-enabled  approach.  In  MS,  the  importance  of  face  to  face
appointments was highlighted as essential for picking up subtle signs of worsening condition.
“You really need to be physically examining the patient as well as hearing their perspective
because there's  subtle  deficits  that  you can pick up on at  examination that  people won't
notice day to day  [..]  you can pick up things like subtle signs like nystagmus, or problems
with the balance or things like that, that people often won't notice” (P01)
In epilepsy too, HCPs reiterated the importance of seeing their patients face to face.
“If their seizure frequency has increased you’re there thinking I probably need to see you,
what else is going on? Have they got a cold, a water infection? Is there something else going
on in their life? Are they not taking their tablets? Sometimes some of those conversations
need to be had.” (P03)
A general practitioner mentioned the relational side of their work as important in the care of people
with depression.
“The relationship element of it is very important, and obviously in primary care a lot of what
I’m thinking is  around depression  [..]  the  human to  human contact  with  someone who’s
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struggling  with  mood,  and  the  fact  that  you’ve  got  someone  who  can  be  empathic  and
rapport rather than just crunching data” (P06)
Theme 7: Empowering patients
HCPs believed that RMT may benefit patients because it might empower them to take a leading role
in their care. Some clinicians thought that patients should lead the use of technology, and therefore
have more control over their own care.
“The way I see it is it’s more about the patient using the data for themselves, the clinician is
almost the passive recipient of the data who is working with the patient to try and interpret it
and help them develop techniques to use the data themselves.” (P07)
HCPs also spoke of how patients could be given full control of their own data collected using RMTs,
and allow that data to be shared with a chosen clinician when they deemed it necessary.
“Within the patient held database,  [..] presumably a sort of secure log in, and that is, it’s
patient-controlled [..] and they could give out the ability to share.” (P15)
Participants provided examples of how a patient could be empowered through the use of RMT, by
determining when to arrange an appointment based on the outputs from the technology.
“Through prospective mood monitoring you could capture periods where there had been a
persistent lowering of mood over two weeks or more with associated other features or even
shorter periods than that,  that you’d agreed as part of  a relapse signature.  What people
could do in those instances is potentially bring appointments forward.” (P13)
However, in the case of depression, participants saw difficulties with patient motivation and thus
thought it unlikely that patients would be able to take control of their own care.
“[That] involves them taking a lot of responsibility for their own healthcare and I guess that
may work better in some conditions, more than depression.” (P16)
For some, it was a case of providing care on an individual basis.
“I would tailor it to what they wanted, so you will have those who are very tech savvy who
don’t have any time and think this will really suit me, others are very much I really want to
see you doctor [..] the key is to listen to them and individualise care rather than doing tick
box medicine which we sometimes do.” (P03)
Theme 8: Alert-based systems
There was debate across all three conditions in the interviews about the potential to use RMT to alert
clinicians when a monitoring variable  fell  outside normative parameters,  for example if  seizures
increased in severity or frequency, if mood or activity were found to be particularly low, or if fatigue
increased.  The  majority  of  participants  considered  such  a  system  to  be  beneficial,  so  that
interventions could be put in place as soon as possible.
“It  would  be  a  system  that  had  parameters  set  and  triggered  active  alerts  when  those
parameters  were exceeded,  I  think  would  be  the  only  way that  I  could see a lot  of  our
consultant body engaging in it.” (P01)
However, a small number thought such a system would be problematic, principally because alerts
may create excessive demand for immediate processing, interpretation and/or response (for example
outside  of  normal  working  hours)  and  there  would  not  be  enough  healthcare  staff  available  to
respond to the alerts produced.
“Outside of fixed appointments the question would be who would actually have time and
headspace to actually look at what was being flagged up. You would need to really carefully
think about the staffing in the NHS and mental health services.” (P13)
HCPs also perceived there to be a risk that alerts would go unnoticed in the system (P03: “My worry
is this data arrives and nobody looks at it for weeks, it’s sitting somewhere in the ether”). Several
participants suggested that it would be more useful if the technology alerted the patient to take action
through their regular treatment pathways, rather than putting the onus on the clinician.
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 “I would want it to prompt the patient to make contact with me.” (P14)
Some saw a need for further research to determine the benefits of an alert-based system.
“Unless  you  could  do  a  good  study  and  demonstrate  that  sending  me  alerts  from  an
automated app would be helpful, then I would just want information that I could look back on
when I next met with a patient face to face” (P14)
Discussion
Principal findings
Eight themes emerged from the analysis of our interviews. The first theme covered the potential
clinical value of remote measurement data. Where RMTs are currently used in healthcare practice,
HCPs  find  them to  be  largely  inaccurate,  particularly  in  the  case  of  epilepsy,  though efforts  to
develop more effective ways of  monitoring  epilepsy are  welcomed.  Participants  were optimistic
about the future use of activity data to monitor symptoms of depression, and considered that using
RMT to collect measures of fatigue and cognition in people with MS would be useful.
In Theme 2, key points in care pathways for the three conditions were identified as times where
RMT data could provide most value. These included monitoring a short period of time prior to an
appointment (MS), monitoring during a change in treatment (epilepsy), and monitoring on a regular
basis once a patient was in a stable condition, to allow assessment of follow-up and to create data for
future research (depression, epilepsy and MS).
The third theme considered staff  roles in  the management  of RMT use by patients.  Participants
suggested all staff involved in a patient’s care should have easy access to data generated by RMTs
via the patient record. Participants also made it clear that triage using data from RMTs should be
conducted by qualified HCPs rather than by administration staff. Primary care staff, and specialist
nurses in secondary care, were thought to be well placed to manage incoming data from patients. 
With regard to presentation of data, in Theme 4, HCPs described ease and speed of access to RMT
data to be important for their successful use, and emphasised the importance of interoperability with
the patient record. Presentation of data in graphs was mentioned as helpful for interpretation.
Theme 5 discussed obstacles  to the successful use of RMTs, and these included both ‘technical
issues’ such as data accuracy and data security (where views differed on the risks involved), and
‘human issues’, such as anxiety created by monitoring (although not all participants agreed that this
was an issue).
In theme 6 on the limits of RMT benefit, participants emphasised that RMT would never completely
replace  face  to  face  appointments,  particularly  in  depression  where  relationship  was  considered
important.
The seventh theme concerned patient empowerment. HCPs expressed the value in giving patients
access to their own data, enabling them to take an active role in their own care, for example by
advancing appointments  where RMT data  indicated  it  was  necessary.  However,  there was some
concern about depression patients having the motivation to take responsibility for their own care.
Theme  8  related  to  alert-based  systems.  Participants  debated  the  value  of  such  systems,  and
highlighted requirements for their successful use. Some thought alerts should be used to invite the
patient to take action rather than alerting a clinician, due to workload concerns. The need for further
research to determine the benefits of alert-based systems was also highlighted.
Comparison with prior work
While prior work exploring RMT in healthcare has principally identified benefits and barriers to its
implementation (e.g. [11] [14]), the present study has investigated HCPs’ perceptions of the clinical
value of implementing RMTs, helping to address a knowledge gap identified by Vegesna et al. [13]
and Davis et al [16]. 
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The themes emerging in this study add to findings from prior work in this area. Our findings support
the work of Bruno et al [18], who highlight that healthcare professionals may view the management
of data from digital devices as a burden. Goodrich and colleagues, among others, have highlighted
the  importance  of  interoperability  and  a  preference  for  data  from  mobile  technologies  to  be
automatically integrated into clinical records [19], similar to the views of our participants. Clinician
concern about the need to respond to alert-based systems has also been raised previously [16, 20]. 
Prior  work has  also emphasised the importance of  face-to-face contact  in  the  context  of  digital
technology and mental health care  [21]. A priority setting exercise for digital  mental health  [15]
identified a need to explore the impact of removing such interactions from care pathways. Our data
has shown that HCPs view face-to-face appointments as essential in the care of patients with these
three conditions, even where RMT could provide them with detailed recent data on a patient’s status.
Our data show too that HCPs imagine patients could be empowered to determine their own need for
a clinical  appointment based on data from RMT, helping to address questions around impact  of
technology on access to services which has also been identified as a research priority [15].
Davis’ Technology Acceptance Model [22] describes perceived usefulness and perceived ease of use
as key mediators to the successful uptake of a new technology. Our analysis  highlights ways in
which clinicians perceive RMT data could be useful (theme 1), as well as where there are limits or
obstacles to this usefulness (themes 5 and 6). We have also identified how speed and ease of access
to data are desirable for HCPs (theme 4), evidencing how perceived ease of use is applicable to this
area. The analysis also raises the tailoring of care for patients using RMT (theme 7), where it was
discussed that patients’ perception of RMT should be that it is both useful and easy to use in order to
motivate continued use.
Beyond  the  findings  presented  in  previous  work,  our  findings  specify  the  types  of  RMT data
clinicians would value in the management of epilepsy, depression and MS, as well as the points in
patient care at which these data would be of most use and the healthcare roles that would be best
placed to manage this data.
Implications for researchers and developers
Findings from these themes will help to inform the development of the RADAR-CNS approach in
the application of RMT for better care for epilepsy, MS and depression. Researchers and companies
developing monitoring technologies should ensure the boundaries of accuracy of any new solution
are well defined, such that clinicians can understand the level of confidence they should place in
readings  from  such  devices.  Since  HCPs  believe  patients  may  benefit  from  the  option  to
move/advance appointments based on their data, it would also be worthwhile for any mobile health
solutions to link with appointment planning services, so that these can be easily accessed. In the
United Kingdom, the NHS app is an example of such a system. 
Strengths and limitations
This study has a number of strengths. We recruited a multidisciplinary group of HCPs working in a
variety  of  clinical  staff  roles  in  primary  and  secondary  care.   Therefore  the  use  of  RMTs  was
considered  from multiple  perspectives.  The study was  limited  in  its  consideration  of  only  three
specific central nervous system disorders in one national health care system. However, the analysis
has considered how insights gained from staff working in these three conditions might generalise,
and has permitted a deeper analysis of the three conditions mentioned. The ratio of male to female
participants was high, with only eight out of 26 participants being female. Epilepsy staff were over-
represented in comparison with depression and multiple sclerosis due to the convenience sampling
method. However, staff were represented across most roles in the care team for each of the three
conditions represented, with the exception of MS, where an MS nurse could not be recruited in the
time available.
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Future directions
While we have focussed our consideration of the use of patient RMT data on an individual basis,
further work could usefully explore the use of combined RMT data from groups of patients to assess
risk or identify trends. The 2019 Topol Review highlighted the potential of integrating predictive
analytics  into  diagnosis  and  care  pathways  [23],  and  data  from  RMTs  could  feed  into  these
approaches. 
Work should also explore the views of health service managers, commissioners and public health
representatives  to  understand  the  value  that  implementation  of  RMTs  could  provide  from  a
healthcare  system  payer  and  management  perspective,  for  example  in  its  potential  to  increase
efficiencies and improve outcomes for different patient populations.
Given participants’ views on the importance of nurses’ roles in the management of patients’ use of
RMT, it would be useful to conduct further research to better understand nurses’ views on subsuming
associated responsibilities into their roles. While some work has explored nurses’ views on their roles
in  use  of  technology  in  intensive  care  situations  [24] and  telehealth  for  diabetes  [25],  to  our
knowledge none has yet explored views specifically relating to RMT in CNS disorders.
Further  work should also be completed to understand how RMTs might best  facilitate increased
patient autonomy (as advocated in the NHS Long Term Plan [26]), and situations where this may be
less  appropriate  or  successful.  The  RADAR-MDD  study  is  recruiting  600  people  with  major
depressive disorder to use RMTs over a period two years, and this study may shed light in this area
[27].
Conclusions
This paper has explored the views of healthcare professionals on implementing remote measurement
technology in the management of central nervous system disorders, specifically in epilepsy, MS and
depression. The results have detailed:
 target physiological variables for measurement that clinicians believe would be useful
 points in care pathways at which clinicians perceive benefit to patients using RMTs
 roles of healthcare staff best placed to manage incoming data
 HCPs’ preferred presentation of data
 obstacles to the successful implementation of RMTs
 limits to the benefits that RMT can provide
 ways in which patients may be empowered through use of RMTs
 considerations around alert-based systems.
Our findings show the importance of early engagement and co-design with healthcare professionals
when considering user requirements and potential use cases before implementing RMT in clinical
care pathways. HCPs believe that  RMT data can add value to the care of patients with these three
conditions, but are not sufficient for decisions about care to be made exclusively on the basis of these
data. We have demonstrated that clinicians are pragmatic about the data security risks of using RMT
data with patients.  Further  research  is  required to  establish  how RMT data could  be used  on a
population level to benefit patients with central nervous system disorders.
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ADHD Attention deficit hyperactivity disorder
CNS Central nervous system
EEG Electroencephalography
EFPIA European Federation of Pharmaceutical Industries and Associations 
EPR Electronic patient record
GPS Global positioning system
HCP Healthcare practitioner
MS Multiple sclerosis
NHS National Health Service
NIHR National Institute for Health Research
RADAR-CNS Remote Assessment of Disease and Relapse – Central nervous system
RADAR-MDD Remote Assessment of Disease and Relapse – Major depressive disorder
RMT Remote measurement technology
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Participant comments about timing of the use of RMT in the epilepsy care pathway, including monitoring on a yearly basis
once stable to allow assessment of follow-up and to create data for future research.
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Participant comments about timing of the use of RMT in the depression care pathway, including monitoring during a change in
treatment.
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Participant comments about timing of the use of RMT in the multiple sclerosis care pathway, indicating the benefits of
monitoring for a short period of time prior to an appointment.
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